Kidney Disease Clinical Trials

Showing 2221-2240 of 3,346 trials

Combination Trial of Intravenous Paracetamol - Morphine for Treating Acute Renal Colic in Emergency Setting: An Optimum Treatment

NCT03865004

This randomized, placebo-controlled trial evaluated the analgesic efficacy and safety of intravenous morphine-paracetamol combination and morphine-dexketoprofen combination morphine for the optimum treatment of renal colic. Combination of IV morphine and paracetamol is as effective and rapid as combination of IV Morphine and IV dexketoprophen for optimum treating of renal colic.

Renal Colic

Akdeniz University136 participantsStarted Oct 2015

WITHDRAWNPhase 1

PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma.

NCT02867332

This study will evaluate the safety of PD-1 knockout engineered T cells in treating metastatic advanced renal cancer. Blood samples will also be collected for research purposes.

Metastatic Renal Cell Carcinoma

Peking UniversityStarted Nov 2016

COMPLETEDPhase 2

Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT01336972

The purpose of the trial was to determine the short-term effects of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD) at various levels of renal function.

Autosomal Dominant Polycystic Kidney Disease

Otsuka Pharmaceutical Development & Commercialization, Inc.29 participantsStarted Oct 2010

Groningen, Netherlands

Combination Trial of Intravenous Paracetamol - Morphine for Treating Acute Renal Colic in Emergency Setting: An Optimum Treatment

PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma.

Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Related Searches

Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction

Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes

Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.

Propaten Randomized Investigation on Cost-benefit and Efficacy

Influence of the Vitamine E Coated Dialyzer on Inflammation and Anemia

Evaluation of Biocompatibility and Performances of 4 Dialyzers in Different Mode Treatments

Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)

Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)

Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Kinetic Analysis

HEmoFiltration With Citric Acid Anticoagulation

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant

Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)

Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)

A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy

Sequential Therapy in Metastatic Renal Cell Carinoma

International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension

Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients